Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (82)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Griffiths, P. D.
Right arrow Articles by Clarke, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffiths, P. D.
Right arrow Articles by Clarke, D. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 4, 667-673, April 1999
© 1999 Oxford University Press

Iron in the basal ganglia in Parkinson's disease

An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

P. D. Griffiths1, B. R. Dobson2, G. R. Jones2 and D. T. Clarke2

1 Academic Department of Radiology, University of Sheffield and 2 CLRC Daresbury Laboratory, Warrington, Cheshire, UK

Correspondence to: Professor Paul D. Griffiths, The University of Sheffield, Academic Department of Radiology, Floor C, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK

Iron is found in high concentration in some areas of the brain, and increased iron in the substantia nigra is a feature of Parkinson's disease. The purpose of this study was to investigate the physical environment of brain iron in post-mortem tissue to provide information on the possible role of iron in neurodegeneration in Parkinson's disease. Iron has also been implicated as the cause of signal loss in areas of high brain iron on T2-weighted MRI sequences. Knowledge of the physical environment of the brain iron is essential in interpreting the cause of signal change. Post-mortem tissue was obtained from six cases of Parkinson's disease and from six age-matched controls. Iron levels were measured using absorption spectrophotometry. Extended X-ray absorption fine structure was used to evaluate the atomic environment of iron within the substantia nigra and both segments of the globus pallidus. Cryo-electron transmission microscopy was used to probe the iron storage proteins in these areas. Iron levels were increased in the parkinsonian nigra and lateral portion of the globus pallidus. Spectra from the extended X-ray absorption fine structure experiments showed that ferritin was the only storage protein detectable in both control and parkinsonian tissue in all areas studied. Cryo-electron transmission microscopy studies showed that ferritin was more heavily loaded with iron in Parkinson's disease when compared with age-matched controls. In summary we have shown that iron levels are increased in two areas of the brain in Parkinson's disease including the substantia nigra, the site of maximal neurodegeneration. This produces increased loading of ferritin, which is the normal brain iron storage protein. It is possible that increased loading of ferritin may increase the risk of free radical-induced damage. Differences in ferritin loading may explain regional differences in iron's effect on the T2 signal.

iron; Parkinson's disease; synchrotron radiation

EXAFS = extended X-ray absorption fine structure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
D. Aquino, A. Bizzi, M. Grisoli, B. Garavaglia, M. G. Bruzzone, N. Nardocci, M. Savoiardo, and L. Chiapparini
Age-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy Subjects
Radiology, July 1, 2009; 252(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Peng, L. Peng, F. F. Stevenson, S. R. Doctrow, and J. K. Andersen
Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration
J. Neurosci., June 27, 2007; 27(26): 6914 - 6922.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
A Mikhaylova, M Davidson, H Toastmann, J.E.T Channell, Y Guyodo, C Batich, and J Dobson
Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy
J R Soc Interface, March 22, 2005; 2(2): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Golts, H. Snyder, M. Frasier, C. Theisler, P. Choi, and B. Wolozin
Magnesium Inhibits Spontaneous and Iron-induced Aggregation of alpha -Synuclein
J. Biol. Chem., May 3, 2002; 277(18): 16116 - 16123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Uversky, J. Li, and A. L. Fink
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human alpha -Synuclein. A POSSIBLE MOLECULAR LINK BETWEEN PARKINSON'S DISEASE AND HEAVY METAL EXPOSURE
J. Biol. Chem., November 16, 2001; 276(47): 44284 - 44296.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. M. Graham, M. N. J. Paley, R. A. Grunewald, N. Hoggard, and P. D. Griffiths
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Brain, December 1, 2000; 123(12): 2423 - 2431.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.